Fukutsuka, K., Iioka, F., Maekawa, F., Nakagawa, M., Kishimori, C., Hayashida, M., . . . Ohno, H. (2021). Burkitt leukemia with precursor B-cell features that developed after ruxolitinib treatment in a patient with hydroxyurea-refractory JAK2(V617F)-myeloproliferative neoplasm. J Clin Exp Hematop.
Styl ChicagoFukutsuka, Katsuhiro, et al. "Burkitt Leukemia With Precursor B-cell Features That Developed After ruxolitinib Treatment in a Patient With Hydroxyurea-refractory JAK2(V617F)-myeloproliferative neoplasm." J Clin Exp Hematop 2021.
Citace podle MLAFukutsuka, Katsuhiro, et al. "Burkitt Leukemia With Precursor B-cell Features That Developed After ruxolitinib Treatment in a Patient With Hydroxyurea-refractory JAK2(V617F)-myeloproliferative neoplasm." J Clin Exp Hematop 2021.